Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model
Because of the toxicity associated with myeloablative conditioning, nonmyeloablative regimens are increasingly being used in vulnerable patient populations. For patients with sickle cell disease, stable mixed chimerism has proven sufficient to reverse the phenotype. Because the vast majority of pati...
Saved in:
Published in | Bone marrow transplantation (Basingstoke) Vol. 48; no. 10; pp. 1335 - 1341 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.10.2013
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Because of the toxicity associated with myeloablative conditioning, nonmyeloablative regimens are increasingly being used in vulnerable patient populations. For patients with sickle cell disease, stable mixed chimerism has proven sufficient to reverse the phenotype. Because the vast majority of patients do not have an HLA-matched sibling, a safe nonmyeloablative regimen that could be applied to the haploidentical setting would be ideal. We employed a mismatched mouse model using BALB/c donors and C57BL/6 recipients. Recipient mice were conditioned with 200 cGy TBI and sirolimus or CSA with or without post transplant Cy (PT-Cy). Our data show that when sirolimus or PT-Cy alone is given to C57BL/6 recipients, donor cells are not detected. However, when sirolimus is administered for 15 or 31 days starting 1 day before or up to 6 days after transplant with PT-Cy, all mice maintain stable mixed chimerism. In contrast, conventional therapy employing CSA with or without PT-Cy does not result in stable mixed chimerism. Lastly, mice with stable mixed chimerism after sirolimus display decreased reactivity to donor Ag both
in vitro
and
in vivo
. These data identify a novel strategy for inducing mixed chimerism for the treatment of nonmalignant hematologic diseases. |
---|---|
AbstractList | Because of the toxicity associated with myeloablative conditioning, nonmyeloablative regimens are increasingly being used in vulnerable patient populations. For patients with sickle cell disease, stable mixed chimerism has proven sufficient to reverse the phenotype. Because the vast majority of patients do not have an HLA-matched sibling, a safe nonmyeloablative regimen that could be applied to the haploidentical setting would be ideal. We employed a mismatched mouse model using BALB/c donors and C57BL/6 recipients. Recipient mice were conditioned with 200cGy TBI and sirolimus or CSA with or without post transplant Cy (PT-Cy). Our data show that when sirolimus or PT-Cy alone is given to C57BL/6 recipients, donor cells are not detected. However, when sirolimus is administered for 15 or 31 days starting 1 day before or up to 6 days after transplant with PT-Cy, all mice maintain stable mixed chimerism. In contrast, conventional therapy employing CSA with or without PT-Cy does not result in stable mixed chimerism. Lastly, mice with stable mixed chimerism after sirolimus display decreased reactivity to donor Ag both in vitro and in vivo. These data identify a novel strategy for inducing mixed chimerism for the treatment of nonmalignant hematologic diseases. Because of the toxicity associated with myeloablative conditioning, nonmyeloablative regimens are increasingly being used in vulnerable patient populations. For patients with sickle cell disease, stable mixed chimerism has proven sufficient to reverse the phenotype. Because the vast majority of patients do not have an HLA-matched sibling, a safe nonmyeloablative regimen that could be applied to the haploidentical setting would be ideal. We employed a mismatched mouse model using BALB/c donors and C57BL/6 recipients. Recipient mice were conditioned with 200cGy TBI and sirolimus or CSA with or without post transplant Cy (PT-Cy). Our data show that when sirolimus or PT-Cy alone is given to C57BL/6 recipients, donor cells are not detected. However, when sirolimus is administered for 15 or 31 days starting 1 day before or up to 6 days after transplant with PT-Cy, all mice maintain stable mixed chimerism. In contrast, conventional therapy employing CSA with or without PT-Cy does not result in stable mixed chimerism. Lastly, mice with stable mixed chimerism after sirolimus display decreased reactivity to donor Ag both in vitro and in vivo. These data identify a novel strategy for inducing mixed chimerism for the treatment of nonmalignant hematologic diseases. Bone Marrow Transplantation (2013) 48, 1335-1341; doi:10.1038/bmt.2013.60; published online 22 April 2013 Keywords: sirolimus; Cy; CSA; mixed chimerism; murine Because of the toxicity associated with myeloablative conditioning, nonmyeloablative regimens are increasingly being used in vulnerable patient populations. For patients with sickle cell disease, stable mixed chimerism has proven sufficient to reverse the phenotype. Because the vast majority of patients do not have an HLA-matched sibling, a safe nonmyeloablative regimen that could be applied to the haploidentical setting would be ideal. We employed a mismatched mouse model using BALB/c donors and C57BL/6 recipients. Recipient mice were conditioned with 200 cGy TBI and sirolimus or CSA with or without post transplant Cy (PT-Cy). Our data show that when sirolimus or PT-Cy alone is given to C57BL/6 recipients, donor cells are not detected. However, when sirolimus is administered for 15 or 31 days starting 1 day before or up to 6 days after transplant with PT-Cy, all mice maintain stable mixed chimerism. In contrast, conventional therapy employing CSA with or without PT-Cy does not result in stable mixed chimerism. Lastly, mice with stable mixed chimerism after sirolimus display decreased reactivity to donor Ag both in vitro and in vivo . These data identify a novel strategy for inducing mixed chimerism for the treatment of nonmalignant hematologic diseases. Because of the toxicity associated with myeloablative conditioning, nonmyeloablative regimens are increasingly being used in vulnerable patient populations. For patients with sickle cell disease, stable mixed chimerism has proven sufficient to reverse the phenotype. Because the vast majority of patients do not have an HLA-matched sibling, a safe nonmyeloablative regimen that could be applied to the haploidentical setting would be ideal. We employed a mismatched mouse model using BALB/c donors and C57BL/6 recipients. Recipient mice were conditioned with 200 cGy TBI and sirolimus or CSA with or without post transplant Cy (PT-Cy). Our data show that when sirolimus or PT-Cy alone is given to C57BL/6 recipients, donor cells are not detected. However, when sirolimus is administered for 15 or 31 days starting 1 day before or up to 6 days after transplant with PT-Cy, all mice maintain stable mixed chimerism. In contrast, conventional therapy employing CSA with or without PT-Cy does not result in stable mixed chimerism. Lastly, mice with stable mixed chimerism after sirolimus display decreased reactivity to donor Ag both in vitro and in vivo. These data identify a novel strategy for inducing mixed chimerism for the treatment of nonmalignant hematologic diseases. |
Audience | Academic |
Author | Tisdale, J F Fitzhugh, C D Weitzel, R P Madison, C Powell, J D Phang, O A Luznik, L Hsieh, M M |
AuthorAffiliation | 1 Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA 2 Sidney-Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
AuthorAffiliation_xml | – name: 1 Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA – name: 2 Sidney-Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA |
Author_xml | – sequence: 1 givenname: C D surname: Fitzhugh fullname: Fitzhugh, C D organization: Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health – sequence: 2 givenname: R P surname: Weitzel fullname: Weitzel, R P organization: Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health – sequence: 3 givenname: M M surname: Hsieh fullname: Hsieh, M M organization: Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health – sequence: 4 givenname: O A surname: Phang fullname: Phang, O A organization: Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health – sequence: 5 givenname: C surname: Madison fullname: Madison, C organization: Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health – sequence: 6 givenname: L surname: Luznik fullname: Luznik, L organization: Sidney-Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine – sequence: 7 givenname: J D surname: Powell fullname: Powell, J D organization: Sidney-Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine – sequence: 8 givenname: J F surname: Tisdale fullname: Tisdale, J F email: johntis@nhlbi.nih.gov organization: Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute/National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27801114$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23604009$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ktuLEzEUxoOsuN3VJ99lQFYEbc1tMjMvwlK8wYIP6nNIM5k2Sy41yYj97z1D624ri4QQOOeXc3K-fBfoLMRgEHpO8IJg1r5b-bKgmLCFwI_QjPBGzGsm6jM0w1S0c8ZEd44ucr7FmHCO6yfonDKBOcbdDA3fbIrO-jFXKvTVNuZSlaRC3joVSrXcVXkXTFrbXKxWzu0qr2wosCtvf5u-0hvrTbLZVxBSEMxeFb2BjB-TDabysTfuKXo8KJfNs8N5iX58_PB9-Xl-8_XTl-X1zVwLVpe5Eo0YxErVGLdYM9bjulWsJaZRmosVaVWtG9EyA_MRtqJ90w-cA0-V0cR07BK939fdjitvem0CDOPkNlmv0k5GZeVpJtiNXMdfkjeY0noq8PpQIMWfo8lFwkTaOFDDxDFLUJCxhhNCAX35D3obxxRgPEkFp6RpMSf_o6bfoB1uSXdPrZUz0oYhwuv01FpeM94RAv8mgFo8QMHqjbcaXDFYiJ9ceHV0YWOUK5sc3VhsDPkUfLMHdYo5JzPcSUawnFwmwWVycpkUGOgXxyrfsX9tBcDVAVAZXDOAobTN9xxIQ6AzcG_3XIZUWJt0JM4Dff8Az4Ho_A |
CODEN | BMTRE9 |
CitedBy_id | crossref_primary_10_1016_j_clim_2015_03_013 crossref_primary_10_1016_j_jtct_2023_02_001 crossref_primary_10_1016_j_omtm_2019_10_017 crossref_primary_10_1182_bloodadvances_2016002972 crossref_primary_10_1016_j_bbmt_2018_02_005 crossref_primary_10_1038_s41409_024_02237_y crossref_primary_10_1053_j_seminhematol_2018_09_002 crossref_primary_10_1016_S2352_3026_19_30154_1 crossref_primary_10_1097_TP_0000000000001480 crossref_primary_10_1016_j_hoc_2022_06_007 crossref_primary_10_1016_j_bbmt_2014_07_020 crossref_primary_10_1200_JCO_20_03502 crossref_primary_10_1038_bmt_2015_50 crossref_primary_10_1182_blood_2014_12_617019 crossref_primary_10_1371_journal_pone_0119950 crossref_primary_10_3390_jcm8111997 crossref_primary_10_1016_j_bbmt_2018_12_779 crossref_primary_10_1038_bmt_2014_19 crossref_primary_10_1200_JCO_22_01203 |
Cites_doi | 10.1097/01.TP.0000164142.98167.4B 10.1111/j.1600-6143.2006.01622.x 10.1053/bbmt.2002.v8.pm11939602 10.1517/14740330903037156 10.1097/00007890-198708000-00021 10.4049/jimmunol.178.11.7018 10.1097/TP.0b013e318242bddf 10.1016/j.immuni.2009.04.014 10.1097/01.tp.0000256158.84418.ff 10.1038/sj.bmt.1701291 10.1038/bmt.2008.203 10.1056/NEJM199608083350601 10.1097/01.tp.0000185299.72295.90 10.1056/NEJMoa0904971 10.1097/00007890-199702150-00005 10.1038/sj.bmt.1705628 10.1182/blood-2011-01-332510 10.1016/j.transproceed.2004.12.147 10.1097/MOH.0b013e32833eaf1b 10.1097/00007890-200004150-00008 10.1016/j.exphem.2008.07.002 10.1016/j.trim.2007.01.002 10.1182/blood.V98.12.3456 10.1016/j.bbmt.2008.03.005 10.1053/bbmt.2001.v7.pm11787529 10.1182/blood-2007-03-079665 10.3324/haematol.2011.058677 10.1097/TP.0b013e3182241133 10.1016/j.exphem.2006.08.018 10.1016/j.bbmt.2012.08.014 10.1182/blood.V99.10.3493 10.1016/S0171-2985(96)80033-7 10.1111/j.1600-6143.2007.01842.x 10.1182/blood-2004-10-3932 10.1681/ASN.V1251059 10.4049/jimmunol.155.9.4179 10.1182/blood.V83.2.600.600 10.4049/jimmunol.162.5.2775 10.4049/jimmunol.151.10.5726 10.1182/blood.V87.9.4001.bloodjournal8794001 10.4049/jimmunol.157.7.2820 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited 2013 2014 INIST-CNRS COPYRIGHT 2013 Nature Publishing Group Copyright Nature Publishing Group Oct 2013 Macmillan Publishers Limited 2013. |
Copyright_xml | – notice: Macmillan Publishers Limited 2013 – notice: 2014 INIST-CNRS – notice: COPYRIGHT 2013 Nature Publishing Group – notice: Copyright Nature Publishing Group Oct 2013 – notice: Macmillan Publishers Limited 2013. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QO 7QP 7T5 7U9 7X7 7XB 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PQEST PQQKQ PQUKI PRINS 5PM |
DOI | 10.1038/bmt.2013.60 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Biotechnology Research Abstracts Calcium & Calcified Tissue Abstracts Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest Central Student MEDLINE ProQuest Central Student Calcium & Calcified Tissue Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1476-5365 |
EndPage | 1341 |
ExternalDocumentID | 3093512171 A349114056 10_1038_bmt_2013_60 23604009 27801114 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z99 HL999999 – fundername: Intramural NIH HHS grantid: ZIA HL006007-06 |
GroupedDBID | --- -Q- .55 .XZ 0R~ 23N 2WC 36B 39C 3V. 4.4 406 53G 5GY 5RE 6J9 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWBL AAZLF ABAKF ABAWZ ABDBF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACIWK ACKTT ACMJI ACPRK ACRQY ACZOJ ADBBV ADFRT ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFFNX AFKRA AFRAH AFSHS AGAYW AGEZK AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DIK DNIVK DPUIP DU5 E3Z EAD EAP EBC EBD EBLON EBS EE. EIOEI EJD EMB EMK EMOBN EPL ESX EX3 F5P FDQFY FEDTE FERAY FIGPU FIZPM FRP FSGXE FYUFA GX1 HCIFZ HMCUK HVGLF HZ~ IAO IH2 IHR IHW INH INR ITC IWAJR J5H JSO JZLTJ KQ8 LGEZI LOTEE M1P M7P N9A NADUK NAO NQJWS NXXTH O9- OK1 OVD P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SNX SNYQT SOHCF SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP X7M ZGI ZXP ~8M AADWK AAPBV AAYJO ABDEU ABFLS ABPTK ACBMV ACBRV ACBYP ACDSR ACIGE ACTTH ACVWB ADGIM ADMDM ADQMX ADYYL AEDAW AEFTE AGGBP AJDOV AMRJV BBAFP IQODW N95 NYICJ PQEST PQUKI W2D ZA5 AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7QP 7T5 7U9 7XB 8FD 8FE 8FH 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. LK8 M7N P64 PRINS 5PM |
ID | FETCH-LOGICAL-c635t-a676f6ba50080c33d058a381e7ac46b18a5c7683e36513b2d7df44ba52aec1e93 |
IEDL.DBID | 7X7 |
ISSN | 0268-3369 |
IngestDate | Tue Sep 17 21:26:07 EDT 2024 Sat Oct 26 00:00:19 EDT 2024 Thu Oct 10 22:18:19 EDT 2024 Thu Oct 10 22:13:39 EDT 2024 Tue Nov 19 21:03:24 EST 2024 Tue Nov 12 23:19:49 EST 2024 Tue Aug 20 22:00:44 EDT 2024 Thu Nov 21 22:00:20 EST 2024 Wed Oct 16 00:59:05 EDT 2024 Fri Nov 25 01:07:21 EST 2022 Fri Oct 11 20:45:53 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | CSA murine mixed chimerism Cy sirolimus Antineoplastic agent Incompatibility Animal model Hematology Sirolimus Rodentia Lactone Macrolide Macrocycle Vertebrata Antibiotic Mammalia Mouse Mixed Animal Protein synthesis inhibitor Chimerism Immunosuppressive agent |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c635t-a676f6ba50080c33d058a381e7ac46b18a5c7683e36513b2d7df44ba52aec1e93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 These authors contributed equally to this work. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702259 |
PMID | 23604009 |
PQID | 1440290819 |
PQPubID | 36075 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4702259 proquest_miscellaneous_1443374112 proquest_journals_2642178041 proquest_journals_1440290819 gale_infotracmisc_A349114056 gale_infotracacademiconefile_A349114056 gale_healthsolutions_A349114056 crossref_primary_10_1038_bmt_2013_60 pubmed_primary_23604009 pascalfrancis_primary_27801114 springer_journals_10_1038_bmt_2013_60 |
PublicationCentury | 2000 |
PublicationDate | 2013-10-01 |
PublicationDateYYYYMMDD | 2013-10-01 |
PublicationDate_xml | – month: 10 year: 2013 text: 2013-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Basingstoke – name: England |
PublicationSubtitle | Official journal of the European Society for Blood and Marrow Transplantation |
PublicationTitle | Bone marrow transplantation (Basingstoke) |
PublicationTitleAbbrev | Bone Marrow Transplant |
PublicationTitleAlternate | Bone Marrow Transplant |
PublicationYear | 2013 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Coenen, Koenen, van Rijssen, Kasran, Boon, Hilbrands (CR28) 2007; 39 Xu, Zhu, Huang, Bozulic, Hussain, Yan (CR13) 2012; 93 Turnquist, Raimondi, Zahorchak, Fischer, Wang, Thomson (CR8) 2007; 178 Mayumi, Umesue, Nomoto (CR22) 1996; 195 Caballero-Velazquez, Sanchez-Abarca, Gutierrez-Cosio, Blanco, Calderon, Herrero (CR42) 2012; 97 Vermylen, Cornu, Ferster, Brichard, Ninane, Ferrant (CR2) 1998; 22 Durakovic, Radojcic, Powell, Luznik (CR7) 2007; 83 Pilat, Klaus, Gattringer, Jaeckel, Wrba, Golshayan (CR36) 2011; 92 Colson, Wren, Schuchert, Patrene, Johnson, Boggs (CR19) 1995; 155 Brook, Waller, Bicknell, Nicholson (CR26) 2005; 37 Hsieh, Fitzhugh, Tisdale (CR6) 2011; 118 Raiola, Dominietto, Ghiso, Di Grazia, Lamparelli, Gualandi (CR41) 2013; 19 Brodsky, Luznik, Bolanos-Meade, Leffell, Jones, Fuchs (CR17) 2008; 42 Luznik, Engstrom, Iannone, Fuchs (CR21) 2002; 8 Taylor, Lees, Blazar (CR35) 2002; 99 Luznik, O’Donnell, Symons, Chen, Leffell, Zahurak (CR16) 2008; 14 Hsieh, Kang, Fitzhugh, Link, Bolan, Kurlander (CR5) 2009; 361 Blazar, Taylor, Sehgal, Vallera (CR29) 1994; 83 Colson, Li, Boggs, Patrene, Johnson, Ildstad (CR20) 1996; 157 Hale, Gottschalk, Fukuzaki, Wood, Maki, Monaco (CR37) 1996; 28 Powell, Fitzhugh, Kang, Hsieh, Schwartz, Tisdale (CR11) 2005; 80 Blazar, Taylor, Panoskaltsis-Mortari, Sehgal, Vallera (CR31) 1996; 87 Hale, Gottschalk, Umemura, Maki, Monaco (CR39) 2000; 69 Walters, Patience, Leisenring, Rogers, Aquino, Buchanan (CR4) 2001; 7 Luznik, Jalla, Engstrom, Iannone, Fuchs (CR18) 2001; 98 Prigozhina, Elkin, Khitrin, Slavin (CR40) 2008; 36 Baan, van der Mast, Klepper, Mol, Peeters, Korevaar (CR10) 2005; 80 Patel, Elliott, Knight, Gaber, Gaber (CR25) 2009; 8 Powell, Lerner, Schwartz (CR9) 1999; 162 Jager, Liu, Timrott, Popp, Stoeltzing, Lang (CR12) 2007; 35 Podder, Stepkowski, Napoli, Clark, Verani, Chou (CR24) 2001; 12 Kean, Adams, Strobert, Hendrix, Gangappa, Jones (CR14) 2007; 7 Qu, Zhang, Zhao, Liu, Ma, Rao (CR34) 2007; 17 Hale, Gottschalk, Fukuzaki, Wood, Maki, Monaco (CR38) 1997; 63 Luznik, Jones, Fuchs (CR15) 2010; 17 Gao, Lu, El Essawy, Oukka, Kuchroo, Strom (CR27) 2007; 7 Walters, Patience, Leisenring, Eckman, Scott, Mentzer (CR3) 1996; 335 Bernaudin, Socie, Kuentz, Chevret, Duval, Bertrand (CR1) 2007; 110 Blazar, Taylor, Snover, Sehgal, Vallera (CR30) 1993; 151 Battaglia, Stabilini, Roncarolo (CR33) 2005; 105 Delgoffe, Kole, Zheng, Zarek, Matthews, Xiao (CR32) 2009; 30 Mayumi, Himeno, Tanaka, Tokuda, Fan, Nomoto (CR23) 1987; 44 8962269 - Transplant Proc. 1996 Dec;28(6):3269 19538929 - Immunity. 2009 Jun 19;30(6):832-44 11719388 - Blood. 2001 Dec 1;98(12):3456-64 11986199 - Blood. 2002 May 15;99(10):3493-9 22940057 - Biol Blood Marrow Transplant. 2013 Jan;19(1):117-22 16003241 - Transplantation. 2005 Jul 15;80(1):110-7 9039923 - Transplantation. 1997 Feb 15;63(3):359-64 20007560 - N Engl J Med. 2009 Dec 10;361(24):2309-17 18489989 - Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50 10072524 - J Immunol. 1999 Mar 1;162(5):2775-84 8286755 - Blood. 1994 Jan 15;83(2):600-9 17606762 - Blood. 2007 Oct 1;110(7):2749-56 8228258 - J Immunol. 1993 Nov 15;151(10):5726-41 17513751 - J Immunol. 2007 Jun 1;178(11):7018-31 21628400 - Blood. 2011 Aug 4;118(5):1197-207 17198885 - Exp Hematol. 2007 Jan;35(1):164-70 15746082 - Blood. 2005 Jun 15;105(12):4743-8 11939602 - Biol Blood Marrow Transplant. 2002;8(3):131-8 17241112 - Am J Transplant. 2007 Feb;7(2):320-35 8816385 - J Immunol. 1996 Oct 1;157(7):2820-9 8611733 - Blood. 1996 May 1;87(9):4001-9 17351648 - Bone Marrow Transplant. 2007 May;39(9):537-45 18622413 - Bone Marrow Transplant. 2008 Oct;42(8):523-7 19522662 - Expert Opin Drug Saf. 2009 Jul;8(4):421-34 21697774 - Transplantation. 2011 Aug 15;92(3):280-8 11787529 - Biol Blood Marrow Transplant. 2001;7(12):665-73 15848549 - Transplant Proc. 2005 Mar;37(2):837-8 3307052 - Transplantation. 1987 Aug;44(2):286-90 8663884 - N Engl J Med. 1996 Aug 8;335(6):369-76 22228418 - Transplantation. 2012 Mar 15;93(5):469-76 10798737 - Transplantation. 2000 Apr 15;69(7):1242-51 11316866 - J Am Soc Nephrol. 2001 May;12(5):1059-71 20827187 - Curr Opin Hematol. 2010 Nov;17(6):493-9 18809241 - Exp Hematol. 2008 Dec;36(12):1750-9 16371922 - Transplantation. 2005 Dec 15;80(11):1541-5 17353785 - Transplantation. 2007 Mar 15;83(5):631-40 7594573 - J Immunol. 1995 Nov 1;155(9):4179-88 22532520 - Haematologica. 2012 Sep;97(9):1329-37 8877390 - Immunobiology. 1996 Jul;195(2):129-39 17511761 - Am J Transplant. 2007 Jul;7(7):1722-32 9678788 - Bone Marrow Transplant. 1998 Jul;22(1):1-6 17331841 - Transpl Immunol. 2007 Apr;17(3):153-61 C Vermylen (BFbmt201360_CR2) 1998; 22 L Luznik (BFbmt201360_CR15) 2010; 17 T Caballero-Velazquez (BFbmt201360_CR42) 2012; 97 W Gao (BFbmt201360_CR27) 2007; 7 N Pilat (BFbmt201360_CR36) 2011; 92 MM Hsieh (BFbmt201360_CR6) 2011; 118 PA Taylor (BFbmt201360_CR35) 2002; 99 H Mayumi (BFbmt201360_CR22) 1996; 195 Y Qu (BFbmt201360_CR34) 2007; 17 DA Hale (BFbmt201360_CR37) 1996; 28 CC Baan (BFbmt201360_CR10) 2005; 80 JD Powell (BFbmt201360_CR11) 2005; 80 MD Jager (BFbmt201360_CR12) 2007; 35 RA Brodsky (BFbmt201360_CR17) 2008; 42 M Battaglia (BFbmt201360_CR33) 2005; 105 L Luznik (BFbmt201360_CR16) 2008; 14 L Luznik (BFbmt201360_CR21) 2002; 8 N Durakovic (BFbmt201360_CR7) 2007; 83 MC Walters (BFbmt201360_CR3) 1996; 335 JD Powell (BFbmt201360_CR9) 1999; 162 L Luznik (BFbmt201360_CR18) 2001; 98 HR Turnquist (BFbmt201360_CR8) 2007; 178 H Xu (BFbmt201360_CR13) 2012; 93 MC Walters (BFbmt201360_CR4) 2001; 7 DA Hale (BFbmt201360_CR39) 2000; 69 DA Hale (BFbmt201360_CR38) 1997; 63 YL Colson (BFbmt201360_CR20) 1996; 157 BR Blazar (BFbmt201360_CR31) 1996; 87 YL Colson (BFbmt201360_CR19) 1995; 155 BR Blazar (BFbmt201360_CR29) 1994; 83 TB Prigozhina (BFbmt201360_CR40) 2008; 36 SJ Patel (BFbmt201360_CR25) 2009; 8 MM Hsieh (BFbmt201360_CR5) 2009; 361 LS Kean (BFbmt201360_CR14) 2007; 7 JJ Coenen (BFbmt201360_CR28) 2007; 39 H Podder (BFbmt201360_CR24) 2001; 12 AM Raiola (BFbmt201360_CR41) 2013; 19 H Mayumi (BFbmt201360_CR23) 1987; 44 NR Brook (BFbmt201360_CR26) 2005; 37 F Bernaudin (BFbmt201360_CR1) 2007; 110 GM Delgoffe (BFbmt201360_CR32) 2009; 30 BR Blazar (BFbmt201360_CR30) 1993; 151 |
References_xml | – volume: 80 start-page: 110 year: 2005 end-page: 117 ident: CR10 article-title: Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells publication-title: Transplantation doi: 10.1097/01.TP.0000164142.98167.4B contributor: fullname: Korevaar – volume: 7 start-page: 320 year: 2007 end-page: 335 ident: CR14 article-title: Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2006.01622.x contributor: fullname: Jones – volume: 8 start-page: 131 year: 2002 end-page: 138 ident: CR21 article-title: Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation publication-title: Biol Blood Marrow Transplant doi: 10.1053/bbmt.2002.v8.pm11939602 contributor: fullname: Fuchs – volume: 8 start-page: 421 year: 2009 end-page: 434 ident: CR25 article-title: Considerations in sirolimus use in the early and late post-transplant periods publication-title: Expert opinion on drug safety doi: 10.1517/14740330903037156 contributor: fullname: Gaber – volume: 162 start-page: 2775 year: 1999 end-page: 2784 ident: CR9 article-title: Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation publication-title: J Immunol contributor: fullname: Schwartz – volume: 12 start-page: 1059 year: 2001 end-page: 1071 ident: CR24 article-title: Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations publication-title: J Am Soc Nephrol contributor: fullname: Chou – volume: 44 start-page: 286 year: 1987 end-page: 290 ident: CR23 article-title: Drug-induced tolerance to allografts in mice. XII. The relationships between tolerance, chimerism, and graft-versus-host disease publication-title: Transplantation doi: 10.1097/00007890-198708000-00021 contributor: fullname: Nomoto – volume: 178 start-page: 7018 year: 2007 end-page: 7031 ident: CR8 article-title: Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance publication-title: J Immunol doi: 10.4049/jimmunol.178.11.7018 contributor: fullname: Thomson – volume: 93 start-page: 469 year: 2012 end-page: 476 ident: CR13 article-title: Innate and adaptive immune responses are tolerized in chimeras prepared with nonmyeloablative conditioning publication-title: Transplantation doi: 10.1097/TP.0b013e318242bddf contributor: fullname: Yan – volume: 30 start-page: 832 year: 2009 end-page: 844 ident: CR32 article-title: The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment publication-title: Immunity doi: 10.1016/j.immuni.2009.04.014 contributor: fullname: Xiao – volume: 83 start-page: 631 year: 2007 end-page: 640 ident: CR7 article-title: Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity publication-title: Transplantation doi: 10.1097/01.tp.0000256158.84418.ff contributor: fullname: Luznik – volume: 22 start-page: 1 year: 1998 end-page: 6 ident: CR2 article-title: Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1701291 contributor: fullname: Ferrant – volume: 157 start-page: 2820 year: 1996 end-page: 2829 ident: CR20 article-title: Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach publication-title: J Immunol contributor: fullname: Ildstad – volume: 28 start-page: 3269 year: 1996 ident: CR37 article-title: Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion publication-title: Transplant Proc contributor: fullname: Monaco – volume: 42 start-page: 523 year: 2008 end-page: 527 ident: CR17 article-title: Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases publication-title: Bone Marrow Transplant doi: 10.1038/bmt.2008.203 contributor: fullname: Fuchs – volume: 335 start-page: 369 year: 1996 end-page: 376 ident: CR3 article-title: Bone marrow transplantation for sickle cell disease publication-title: N Engl J Med doi: 10.1056/NEJM199608083350601 contributor: fullname: Mentzer – volume: 80 start-page: 1541 year: 2005 end-page: 1545 ident: CR11 article-title: Low-dose radiation plus rapamycin promotes long-term bone marrow chimerism publication-title: Transplantation doi: 10.1097/01.tp.0000185299.72295.90 contributor: fullname: Tisdale – volume: 83 start-page: 600 year: 1994 end-page: 609 ident: CR29 article-title: Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow publication-title: Blood contributor: fullname: Vallera – volume: 361 start-page: 2309 year: 2009 end-page: 2317 ident: CR5 article-title: Allogeneic hematopoietic stem-cell transplantation for sickle cell disease publication-title: N Engl J Med doi: 10.1056/NEJMoa0904971 contributor: fullname: Kurlander – volume: 63 start-page: 359 year: 1997 end-page: 364 ident: CR38 article-title: Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow publication-title: Transplantation doi: 10.1097/00007890-199702150-00005 contributor: fullname: Monaco – volume: 39 start-page: 537 year: 2007 end-page: 545 ident: CR28 article-title: Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1705628 contributor: fullname: Hilbrands – volume: 118 start-page: 1197 year: 2011 end-page: 1207 ident: CR6 article-title: Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now publication-title: Blood doi: 10.1182/blood-2011-01-332510 contributor: fullname: Tisdale – volume: 37 start-page: 837 year: 2005 end-page: 838 ident: CR26 article-title: Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage publication-title: Transplant Proc doi: 10.1016/j.transproceed.2004.12.147 contributor: fullname: Nicholson – volume: 17 start-page: 493 year: 2010 end-page: 499 ident: CR15 article-title: High-dose cyclophosphamide for graft-versus-host disease prevention publication-title: Curr Opin Hematol doi: 10.1097/MOH.0b013e32833eaf1b contributor: fullname: Fuchs – volume: 69 start-page: 1242 year: 2000 end-page: 1251 ident: CR39 article-title: Establishment of stable multilineage hematopoietic chimerism and donor- specific tolerance without irradiation publication-title: Transplantation doi: 10.1097/00007890-200004150-00008 contributor: fullname: Monaco – volume: 36 start-page: 1750 year: 2008 end-page: 1759 ident: CR40 article-title: Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation publication-title: Exp Hematol doi: 10.1016/j.exphem.2008.07.002 contributor: fullname: Slavin – volume: 87 start-page: 4001 year: 1996 end-page: 4009 ident: CR31 article-title: inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical–pathological syndrome discrete from that observed with cyclosporin A publication-title: Blood contributor: fullname: Vallera – volume: 17 start-page: 153 year: 2007 end-page: 161 ident: CR34 article-title: The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice publication-title: Transpl. Immunol doi: 10.1016/j.trim.2007.01.002 contributor: fullname: Rao – volume: 151 start-page: 5726 year: 1993 end-page: 5741 ident: CR30 article-title: Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by the administration of rapamycin but develop an autoimmune-like syndrome publication-title: J Immunol contributor: fullname: Vallera – volume: 98 start-page: 3456 year: 2001 end-page: 3464 ident: CR18 article-title: Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide publication-title: Blood doi: 10.1182/blood.V98.12.3456 contributor: fullname: Fuchs – volume: 14 start-page: 641 year: 2008 end-page: 650 ident: CR16 article-title: HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2008.03.005 contributor: fullname: Zahurak – volume: 7 start-page: 665 year: 2001 end-page: 673 ident: CR4 article-title: Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia publication-title: Biol Blood Marrow Transplant doi: 10.1053/bbmt.2001.v7.pm11787529 contributor: fullname: Buchanan – volume: 110 start-page: 2749 year: 2007 end-page: 2756 ident: CR1 article-title: Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease publication-title: Blood doi: 10.1182/blood-2007-03-079665 contributor: fullname: Bertrand – volume: 97 start-page: 1329 year: 2012 end-page: 1337 ident: CR42 article-title: The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation publication-title: Haematologica doi: 10.3324/haematol.2011.058677 contributor: fullname: Herrero – volume: 92 start-page: 280 year: 2011 end-page: 288 ident: CR36 article-title: Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model publication-title: Transplantation doi: 10.1097/TP.0b013e3182241133 contributor: fullname: Golshayan – volume: 155 start-page: 4179 year: 1995 end-page: 4188 ident: CR19 article-title: A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers publication-title: J Immunol contributor: fullname: Boggs – volume: 35 start-page: 164 year: 2007 end-page: 170 ident: CR12 article-title: Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats publication-title: Exp Hematol doi: 10.1016/j.exphem.2006.08.018 contributor: fullname: Lang – volume: 19 start-page: 117 year: 2013 end-page: 122 ident: CR41 article-title: Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2012.08.014 contributor: fullname: Gualandi – volume: 99 start-page: 3493 year: 2002 end-page: 3499 ident: CR35 article-title: The infusion of activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality publication-title: Blood doi: 10.1182/blood.V99.10.3493 contributor: fullname: Blazar – volume: 195 start-page: 129 year: 1996 end-page: 139 ident: CR22 article-title: Cyclophosphamide-induced immunological tolerance: an overview publication-title: Immunobiology doi: 10.1016/S0171-2985(96)80033-7 contributor: fullname: Nomoto – volume: 7 start-page: 1722 year: 2007 end-page: 1732 ident: CR27 article-title: Contrasting effects of cyclosporine and rapamycin in generation of alloantigen-specific regulatory T cells publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2007.01842.x contributor: fullname: Strom – volume: 105 start-page: 4743 year: 2005 end-page: 4748 ident: CR33 article-title: Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells publication-title: Blood doi: 10.1182/blood-2004-10-3932 contributor: fullname: Roncarolo – volume: 178 start-page: 7018 year: 2007 ident: BFbmt201360_CR8 publication-title: J Immunol doi: 10.4049/jimmunol.178.11.7018 contributor: fullname: HR Turnquist – volume: 28 start-page: 3269 year: 1996 ident: BFbmt201360_CR37 publication-title: Transplant Proc contributor: fullname: DA Hale – volume: 7 start-page: 1722 year: 2007 ident: BFbmt201360_CR27 publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2007.01842.x contributor: fullname: W Gao – volume: 36 start-page: 1750 year: 2008 ident: BFbmt201360_CR40 publication-title: Exp Hematol doi: 10.1016/j.exphem.2008.07.002 contributor: fullname: TB Prigozhina – volume: 98 start-page: 3456 year: 2001 ident: BFbmt201360_CR18 publication-title: Blood doi: 10.1182/blood.V98.12.3456 contributor: fullname: L Luznik – volume: 39 start-page: 537 year: 2007 ident: BFbmt201360_CR28 publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1705628 contributor: fullname: JJ Coenen – volume: 80 start-page: 1541 year: 2005 ident: BFbmt201360_CR11 publication-title: Transplantation doi: 10.1097/01.tp.0000185299.72295.90 contributor: fullname: JD Powell – volume: 19 start-page: 117 year: 2013 ident: BFbmt201360_CR41 publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2012.08.014 contributor: fullname: AM Raiola – volume: 83 start-page: 631 year: 2007 ident: BFbmt201360_CR7 publication-title: Transplantation doi: 10.1097/01.tp.0000256158.84418.ff contributor: fullname: N Durakovic – volume: 12 start-page: 1059 year: 2001 ident: BFbmt201360_CR24 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.V1251059 contributor: fullname: H Podder – volume: 37 start-page: 837 year: 2005 ident: BFbmt201360_CR26 publication-title: Transplant Proc doi: 10.1016/j.transproceed.2004.12.147 contributor: fullname: NR Brook – volume: 99 start-page: 3493 year: 2002 ident: BFbmt201360_CR35 publication-title: Blood doi: 10.1182/blood.V99.10.3493 contributor: fullname: PA Taylor – volume: 69 start-page: 1242 year: 2000 ident: BFbmt201360_CR39 publication-title: Transplantation doi: 10.1097/00007890-200004150-00008 contributor: fullname: DA Hale – volume: 44 start-page: 286 year: 1987 ident: BFbmt201360_CR23 publication-title: Transplantation doi: 10.1097/00007890-198708000-00021 contributor: fullname: H Mayumi – volume: 63 start-page: 359 year: 1997 ident: BFbmt201360_CR38 publication-title: Transplantation doi: 10.1097/00007890-199702150-00005 contributor: fullname: DA Hale – volume: 7 start-page: 665 year: 2001 ident: BFbmt201360_CR4 publication-title: Biol Blood Marrow Transplant doi: 10.1053/bbmt.2001.v7.pm11787529 contributor: fullname: MC Walters – volume: 155 start-page: 4179 year: 1995 ident: BFbmt201360_CR19 publication-title: J Immunol doi: 10.4049/jimmunol.155.9.4179 contributor: fullname: YL Colson – volume: 8 start-page: 131 year: 2002 ident: BFbmt201360_CR21 publication-title: Biol Blood Marrow Transplant doi: 10.1053/bbmt.2002.v8.pm11939602 contributor: fullname: L Luznik – volume: 30 start-page: 832 year: 2009 ident: BFbmt201360_CR32 publication-title: Immunity doi: 10.1016/j.immuni.2009.04.014 contributor: fullname: GM Delgoffe – volume: 118 start-page: 1197 year: 2011 ident: BFbmt201360_CR6 publication-title: Blood doi: 10.1182/blood-2011-01-332510 contributor: fullname: MM Hsieh – volume: 92 start-page: 280 year: 2011 ident: BFbmt201360_CR36 publication-title: Transplantation doi: 10.1097/TP.0b013e3182241133 contributor: fullname: N Pilat – volume: 110 start-page: 2749 year: 2007 ident: BFbmt201360_CR1 publication-title: Blood doi: 10.1182/blood-2007-03-079665 contributor: fullname: F Bernaudin – volume: 83 start-page: 600 year: 1994 ident: BFbmt201360_CR29 publication-title: Blood doi: 10.1182/blood.V83.2.600.600 contributor: fullname: BR Blazar – volume: 17 start-page: 493 year: 2010 ident: BFbmt201360_CR15 publication-title: Curr Opin Hematol doi: 10.1097/MOH.0b013e32833eaf1b contributor: fullname: L Luznik – volume: 42 start-page: 523 year: 2008 ident: BFbmt201360_CR17 publication-title: Bone Marrow Transplant doi: 10.1038/bmt.2008.203 contributor: fullname: RA Brodsky – volume: 335 start-page: 369 year: 1996 ident: BFbmt201360_CR3 publication-title: N Engl J Med doi: 10.1056/NEJM199608083350601 contributor: fullname: MC Walters – volume: 195 start-page: 129 year: 1996 ident: BFbmt201360_CR22 publication-title: Immunobiology doi: 10.1016/S0171-2985(96)80033-7 contributor: fullname: H Mayumi – volume: 97 start-page: 1329 year: 2012 ident: BFbmt201360_CR42 publication-title: Haematologica doi: 10.3324/haematol.2011.058677 contributor: fullname: T Caballero-Velazquez – volume: 93 start-page: 469 year: 2012 ident: BFbmt201360_CR13 publication-title: Transplantation doi: 10.1097/TP.0b013e318242bddf contributor: fullname: H Xu – volume: 22 start-page: 1 year: 1998 ident: BFbmt201360_CR2 publication-title: Bone Marrow Transplant doi: 10.1038/sj.bmt.1701291 contributor: fullname: C Vermylen – volume: 8 start-page: 421 year: 2009 ident: BFbmt201360_CR25 publication-title: Expert opinion on drug safety doi: 10.1517/14740330903037156 contributor: fullname: SJ Patel – volume: 162 start-page: 2775 year: 1999 ident: BFbmt201360_CR9 publication-title: J Immunol doi: 10.4049/jimmunol.162.5.2775 contributor: fullname: JD Powell – volume: 17 start-page: 153 year: 2007 ident: BFbmt201360_CR34 publication-title: Transpl. Immunol doi: 10.1016/j.trim.2007.01.002 contributor: fullname: Y Qu – volume: 35 start-page: 164 year: 2007 ident: BFbmt201360_CR12 publication-title: Exp Hematol doi: 10.1016/j.exphem.2006.08.018 contributor: fullname: MD Jager – volume: 7 start-page: 320 year: 2007 ident: BFbmt201360_CR14 publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2006.01622.x contributor: fullname: LS Kean – volume: 151 start-page: 5726 year: 1993 ident: BFbmt201360_CR30 publication-title: J Immunol doi: 10.4049/jimmunol.151.10.5726 contributor: fullname: BR Blazar – volume: 361 start-page: 2309 year: 2009 ident: BFbmt201360_CR5 publication-title: N Engl J Med doi: 10.1056/NEJMoa0904971 contributor: fullname: MM Hsieh – volume: 87 start-page: 4001 year: 1996 ident: BFbmt201360_CR31 publication-title: Blood doi: 10.1182/blood.V87.9.4001.bloodjournal8794001 contributor: fullname: BR Blazar – volume: 80 start-page: 110 year: 2005 ident: BFbmt201360_CR10 publication-title: Transplantation doi: 10.1097/01.TP.0000164142.98167.4B contributor: fullname: CC Baan – volume: 14 start-page: 641 year: 2008 ident: BFbmt201360_CR16 publication-title: Biol Blood Marrow Transplant doi: 10.1016/j.bbmt.2008.03.005 contributor: fullname: L Luznik – volume: 157 start-page: 2820 year: 1996 ident: BFbmt201360_CR20 publication-title: J Immunol doi: 10.4049/jimmunol.157.7.2820 contributor: fullname: YL Colson – volume: 105 start-page: 4743 year: 2005 ident: BFbmt201360_CR33 publication-title: Blood doi: 10.1182/blood-2004-10-3932 contributor: fullname: M Battaglia |
SSID | ssj0014405 |
Score | 2.247934 |
Snippet | Because of the toxicity associated with myeloablative conditioning, nonmyeloablative regimens are increasingly being used in vulnerable patient populations.... |
SourceID | pubmedcentral proquest gale crossref pubmed pascalfrancis springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1335 |
SubjectTerms | 631/250/1904 692/699/1541 692/700/565/251/1574 Analysis Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Animal models Animals Biocompatibility Biological and medical sciences Blood diseases Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Care and treatment Cell Biology Chimeras (Organisms) Chimerism Conditioning Cyclophosphamide - pharmacology Disease Models, Animal Dosage and administration Drug Synergism Female Hematological diseases Hematology Histocompatibility antigen HLA Immunosuppressive Agents - pharmacology Internal Medicine Medical sciences Medicine Medicine & Public Health Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred NOD original-article Patients Phenotypes Physiological aspects Public Health Rapamycin Sickle cell disease Sirolimus - pharmacology Skin Transplantation - methods Stem cell transplantation Stem Cells Toxicity Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Chimera |
Title | Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model |
URI | https://link.springer.com/article/10.1038/bmt.2013.60 https://www.ncbi.nlm.nih.gov/pubmed/23604009 https://www.proquest.com/docview/1440290819 https://www.proquest.com/docview/2642178041 https://search.proquest.com/docview/1443374112 https://pubmed.ncbi.nlm.nih.gov/PMC4702259 |
Volume | 48 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9QwLIJNQkgT4puO7QjSEE9lbdOk7RPaxqYBYkLApHur0iTVKl17t7Uncf8eO831KJt4bOO0qe3Yru3YhBwUKYt5WBhfpibw4xhL3oa69CMwLTjDfoylTZC9EOeX8ZcpnzqHW-vSKtcy0QpqPVfoIz_EIGSUoQL7uLj2sWsURlddC437ZDuMQJUDPyfT4YcLp_Dex5L6jInMnc8LWHpY1JhIGbIPtjblRiM5ubyzkC3gqOybW9xlfd5OovwnkmoV1Nlj8shZlvSoZ4Un5J5pnpIH31zs_Bkpf1bYoadetlQ2mi7mbUc7W9p8BtilJyvarvAgoK3cLGezFa1l1aDngNbVb6OpuqowvNPWFG5JuNmCtQs017RGl72htqvOc3J5dvrr5Nx3XRZ8BcZG50uRiFIU2BkhDRRjOuCpBD1uEqliUYSp5Ar-SZhhgoesiHSiyzgG-EgaFZqMvSBbzbwxrwjVodFMGLCJMh0nIBu4ygwPmDIZRzvFIwdrTOeLvphGboPgLM2BIDkSJBeBR94gFfL-JOiwBfMjFoNoBpoKj7y3ELgJAVNKurMEsAwsZzWC3BtBAm7UaHgyovSwrCgB1Q0wMH9N-tzt7jbf8OKdwxEeHraFnTzydhjGN2NCW2PmS_sIxsCaCyOPvOwZafNuJlC0wsOTEYsNAFgSfDzSVFe2NDhgHQQ0zHy3Zsa_Vn0b07v__7rX5CEC9rmLe2Sru1mafbDBumJiN9qEbB-fXnz_AVefPn_9A4fWMcU |
link.rule.ids | 230,314,780,784,885,12056,21388,27924,27925,31719,31720,33744,33745,43310,43805,73745,74302 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJOAiSE-CYwNiMN8ZQtiWMneUJj2lRgqxBs0t4ix3a0SE3aLa1E_z13jpsSNvEanxP37nx3vU9C9oqUxTwsjC9TE_hxjC1vQ136EZgWnOE8xtImyE7E-CL-dskvncOtdWmVa5loBbWeKfSRH2AQMspQgX2eX_s4NQqjq26Exn2yhZ3T-YhsfTme_PjZxxFgE--8LKnPmMhchV7A0oOixlTKkO3b7pQbneQk8-O5bAFLZTfe4i7783Ya5T-xVKuiTp6SJ862pIcdMzwj90zznDw4c9HzF6T8VeGMnnrZUtloOp-1C7qwzc2ngF96tKLtCksBbe9mOZ2uaC2rBn0HtK5-G03VVYUBnram8EjCwxbsXaC6pjU67Q21c3VekouT4_Ojse_mLPgKzI2FL0UiSlHgbIQ0UIzpgKcSNLlJpIpFEaaSK_hXwgwTPGRFpBNdxjHAR9Ko0GTsFRk1s8a8IVSHRjNhwCrKdJyAdOAqMzxgymQcLRWP7K0xnc-7dhq5DYOzNAeC5EiQXAQe2UUq5F0taH8J80MWg3AGmgqPfLIQeA0BU0q6agI4Bja0GkBuDyABN2qwvDOgdH-sKAHlDTCwf0363N3vNt9w453LEZYP29ZOHvnQL-OXMaWtMbOlfQVjYM-FkUded4y0-TYTKFzh5cmAxXoAbAo-XGmqK9scHLAOIhp2flwz41-nvo3pt___dbvk4fj87DQ__Tr5_o48wk1dJuM2GS1uluY9WGSLYsdduz9qbTOI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJOmpAQ4puMsRlpiKfQJE6c5AmNsWp8VRMwaW-WYztapCYtSyrRf8-d47aETbzGZ8e5O99dfF-EHBUZi5OwML7MTODHMZa8DXXpR2BaJAz7MZY2QHbKzy7iz5fJpYt_al1Y5VomWkGt5wrvyMfohIxyVGDj0oVFnH-cvF_88rGDFHpaXTuNu2QHtGIQjcjOh9Pp-feNTwEWSPobl8xnjOcuWy9g2bioMawyZO9spcqtfnJS-v5CtoCxsm91cZstejOk8h-_qlVXk4fkgbMz6XHPGI_IHdM8JrvfnCf9CSl_VNivp162VDaaLuZtRztb6HwGuKYnK9quMC3Q1nGWs9mK1rJq8B6B1tVvo6m6qtDZ09YUHkl42ILtCxygaY0X-IbaHjtPycXk9OfJme96LvgKTI_OlzzlJS-wT0IWKMZ0kGQStLpJpYp5EWYyUfCHwgzjSciKSKe6jGOAj6RRocnZMzJq5o15QagOjWbcgIWU6zgFSZGo3CQBUyZP0GrxyNEa02LRl9YQ1iXOMgEEEUgQwQOPHCIVRJ8XujmQ4pjFIKiBptwjby0EHknAlJIuswC2gcWtBpD7A0jAjRoMHwwovdlWlIIiBxiYvya9cGe9FVvOvHU4wlRiW-bJI683w_hmDG9rzHxpl2AMbLsw8sjznpG272YcBS0sng5YbAOABcKHI011ZQuFA9ZBXMPMN2tm_GvXNzG99_-vOyS7cOLE10_TLy_JPZzTBzXuk1F3vTSvwDjrigN36v4A41Q3tQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Sirolimus+and+post+transplant+Cy+synergistically+maintain+mixed+chimerism+in+a+mismatched+murine+model&rft.jtitle=Bone+marrow+transplantation+%28Basingstoke%29&rft.au=Fitzhugh%2C+C+D&rft.au=Weitzel%2C+R+P&rft.au=Hsieh%2C+M+M&rft.au=Phang%2C+O+A&rft.date=2013-10-01&rft.eissn=1476-5365&rft.volume=48&rft.issue=10&rft.spage=1335&rft_id=info:doi/10.1038%2Fbmt.2013.60&rft_id=info%3Apmid%2F23604009&rft.externalDocID=23604009 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-3369&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-3369&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-3369&client=summon |